Oxidative stress in systemic sclerosis

Molecular and Cellular Biochemistry

Volumn 196, Issue 1-2, 1999, Pages 85-91

  Simonini, Gabriele ^b   Cerinic, Marco Matucci ^c   Generini, Sergio ^c   Zoppi, Massimo ^c   Anichini, Mario ^a   Cesaretti, C ^a   Pignone, Alberto ^c   Falcini, Fernanda ^c   Lotti, Torello ^c   Cagnoni, Mario ^c  

^a INRCA   (Italy)

^b Rheumatology Unit   (Italy)

^c NONE

Author keywords

Antibodies against oxidised low density lipoproteins; Diene conjugates; Oxidative stress; Reperfusion injury; Systemic sclerosis

Indexed keywords

ALKADIENE; ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OXIDATIVE STRESS; PEROXIDATION; RAYNAUD PHENOMENON; REPERFUSION; RESPIRATORY BURST; SPECTROPHOTOMETRY; SYSTEMIC SCLEROSIS;

ANTIBODIES; FEMALE; FREE RADICALS; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; SCLERODERMA, SYSTEMIC;

EID: 0032768998     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006922313774     Document Type: Article

References (53)

1. Matucci Cerinic M, Kahaleh BM, LeRoy EC: The vascular involvement in systemic sclerosis. In: P.J. Clements, D.E. Furst (eds). Systemic Sclerosis. Baltimore, 1996, pp 153-174
2. Murrel DF: A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 28: 78-85, 1993
3. Mapp PI, Grootveld MC, Blake DR: Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 51: 419-436, 1995
4. Halliwell B, Gutteridge JMC: Free radicals in biology and medicine. Clarendon Press, Oxford, 1989
5. Rowley D, Gutteridge JMC, Blake D, Farr M, Halliwell B: Lipid peroxidation in rheumatoid arthritis: Thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci 66: 691-695, 1984
6. Biemond P, Swaak AJG, Koster JF: Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arth Rheum 27: 760-765, 1984
7. Candeias LP: Free hydroxyl radicals are formed on reaction between oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arth Rheum 27: 760-765, 1984
8. Rathakrishnan C, Tiku K, Raghavan A, Tiku ML: Release of oxygen radicals by articular chondrocytes. J Bone Miner Res 7: 1139-1148, 1992
9. Key LL Jr, Ries WL, Glassocock H, Rodriguiz R, Jaffe H: Osteoclastic superoxide generation. Int J Tissue React 14: 295-298, 1992
10. Jarasch ED, Grund C, Bruder G: Localization of xanthine oxidase in mammary gland epithelium and capillary endothelium. Cell 25: 67-82, 1981
11. Della Corte E, Stirpe F: The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type )) and purification of the enzyme. Biochem J 126: 739-745, 1972
12. McCord JM, Roy RS, Schaffer SW: Free radicals and myocardial ischemia: The role of xanthine oxidase. Adv Myocardiol 5: 183-189, 1985
13. Granger DN, Holloworth ME, Parks DA: Ischaemia-reperfusion injury: Role of oxygen derived free radicals. Acta Physiol Scand 548: 47-63, 1986
14. Merry P, Grootveld M, Lunec J, Blake DR: Oxidative damage to lipids within the inflamed human joint provides evidence of radical-mediated hypoxic-reperfusion injury. Am J Clin Nutr 53: 362S-369S, 1991
15. Henderson E, Winyard M, Grootveld MC, Blake DR: Pathophysiology of reperfusion injury in human joints. In: D.K. Das (ed). Pathophysiology of Reperfusion Injury. CRC Press, Boca Raton, FL, 1995, pp 429-470
16. Hovdens J, Hovdens AB, Egeland T: A study of the effect of rheumatoid synovial fluid on proliferation and IL-2 production by total mononuclear cells and purified CD4+ cells of synovial fluid and peripheral blood. Scand J Rheumatol 19: 398-406, 1990
17. Shingu M, Yoshioka K, Nobunaga M: Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide. Inflammation 9: 309-320, 1985
18. Mead JF: In W.A.J. Pryor (ed). Free Radicals in Biology, Vol. 1. Academic Press, New York, 1976, pp 51-68
19. Winyard PG, Tatzeber F, Esterbauer H, Kus ML, Morris CJ, Blake DR: Presence of foam cells containing oxidised low density lipoprotein in rheumatoid synovial membrane. Ann Rheum Dis 52: 677-680, 1993
20. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jurges G: Biochemical structural and functional properties of oxidised low-density lipoprotein. Chem Res Toxicol 3: 77-92, 1990
21. Kalant N, McCornick S, Parniak MA: Effects of copper and histidine on oxidative modification of low density lipoprotein and its subsequent binding to collagen. Arterioscler Thromb 11: 1322-1329, 1991
22. Morris CJ, Bradby GVH, Walton KW: Fibrous longspacing collagen in human atherosclerosis. Atherosclerosis 31: 345-354, 1978
23. Berliner JA, Territo MC, Sevanian A: Minimally modified low density lipoprotein stimulates monocyte endothelial cell interactions. J Clin Invest 85: 1260-1266, 1990
24. Iauen W, Payne DK, Kvietys PR: Hyposica/reoxygenation increases the permeability of endothelial cell monolayers: Role of oxygen radicals. Free Rad Biol Med 9: 219-233, 1990
25. Parks DA, Granger DN: Ischemia-induced vascular changes. Role of xanthine oxidase and hydroxyl radicals. Am J Physiol 245: 285-289, 1983
26. Maslen CL, Hall ND, Woolf AD, Maddison PJ: Enhanced oxidative metabolism of neutrophils from patients with systemic sclerosis. Br J Rheumatol 26: 113-117, 1987
27. Czirjak L, Danko K, Sipka S, Zeher M, Szegedi G: Polymorphonuclear neutrophil function in systemic sclerosis. Ann Rheum Dis 46: 302-306, 1987
28. Murrel GAC, Francis MJO, Bromley L: Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265: 659-665, 1990
29. Del Maestro RF, Thaw HH, Bjork J: Free radicals as mediators of tissue injury. Acta Physiol Scand 492: 43-57, 1980
30. LeRoy EC, Black C, Fleischmajer R: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 15: 202-205, 1988
31. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Met Enzymol 186: 407-413, 1990
32. Virella G, Virella I, Lennon RB, Prior MB, Virella M: Anti oxidised low density apoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res 23: 95-101, 1993
33. Esterbauer H, Striegel G, Pahl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Res Commun 6: 67-75, 1989
34. Rosen A, Casciola-Rosen L, Wigley F: Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma. Curr Opin Rheumatol 9: 538-543, 1997
35. Stein CM, Tanner SB, Awad JA, Roberts LJ II, Morrow JD: Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arth Rheum 39: 1146-1150, 1996
36. Emerit I: Reactive oxygen species, chromosome mutation and cancer: Possible role of clastogenic factor in carcinogenesis. Free Rad Biol Med 16: 99-109, 1994
37. Casciola-Rosen L, Wigley F, Rosen A: Scleroderma autoantigens are uniquely fragmented by metal catalyzed oxidation reactions: Implications for pathogenesis. J Exp Med 185: 71-79, 1997
38. Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MI: Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis. J Rheumatol 21: 1477-1483, 1994
39. Lundberg AC, Akesson A, Akesson B: Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 51: 1143-1148, 1992
40. Herrick AL, Worthington H, Rieley F, Clarke D, Schofield D, Braganza JM, Jayson MIV: Dietary intake of micronutrient antioxidant in relation to blood levels in patients with systemic sclerosis. J Rheumatol 23: 650-653, 1996
41. Herrik AL, Rieley F, Braganza JM, Jayson MIV: Difficulty in detecting reperfusion injury increment in oxidative stress among patients with primary Raynaud's phenomenon and systemic sclerosis. J Rheumatol 22: 374-375, 1995
42. Morita A, Minami H, Sakakibara N, Sato K, Tsuji TAD: Elevated plasma superoxide dismutase activity in patients with systemic sclerosis. J Dermatol Sci 11: 196-201, 1996
43. Blann AD, Illingworth K, Jayson MIV: Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's Phenomenon. J Rheumatol 20: 1325-1330, 1993
44. Bruckdorfer KR, Hillary JB, Bunce T, Vancheeswaran R, Black CM: Increased susceptibility to oxidation of low density lipoproteins isolated from patients with systemic sclerosis. Arth Rheum 38: 1060-1067, 1995
45. Halliwell B, Chirico S: Lipid peroxidation: Its mechanism, measurement, and significance. Am J Clin Nutr 57: 715S-724S, 1993
46. Andrews B, Burnand K, Paganga G, Browse N, Rice-Evans C, Sommerville K, Leake D, Taub N: Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis. Atherosclerosis 112: 77-84, 1995
47. Hamilton CA: Low-density lipoprotein and oxidised low-density lipoprotein: Their role in the development of atherosclerosis. Pharmacol Ther 74: 55-72, 1997
48. Gokce N, Frei B: Basis research in antioxidant inhibition of steps in atherogenesis. J Cardiovasc Risk 3: 352-357, 1996
49. Gorog P: Modified low density lipoprotein is a potent stimulus for smooth muscle cell outgrowth from rat aortic explant in vitro. Atherosclerosis 129: 1-7, 1997
50. Thorne SA, Abbot SE, Winyard PG, Blake DR, Mills PG: Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells. Heart 75: 11-16, 1996
51. Massaeli H, Pierce GN: Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes. Cardiovasc Res 29: 597-603, 1995
52. Maggi E, Perani G, Falaschi F, Frattoni A, Martignoni A, Finardi G, Stefano PL, Simeone F, Paolini G, DeVecchi E: Autoantibodies against oxidised low density lipoproteins in patients with coronary disease. Press Med 23: 1158-1162, 1994
53. Blake DR, Winyard P, Scott DGI, Brailsford S, Blann A, Lunec J: Endothelial cell cytotoxicity in inflammatory vascular disease: The possible role of oxidised lipoproteins. Ann Rheum Dis 44: 176-184, 1985